• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
No Result
View All Result
Tuesday, January 31, 2023
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
No Result
View All Result
Alternatives Watch
No Result
View All Result

Medical Excellence closes inaugural venture fund at $145m

Susan BarretobySusan Barreto
August 24, 2022
in Manager News, Open Access, Private Equity
Medical Excellence closes inaugural venture fund at $145m

By halfpoint/Envato Elements

ShareTweetShareSendSend

Early-stage life science venture firm Medical Excellence Capital closed on $145 million for its Medical Excellence Capital Partners (MEC) fund.

Founded by John Prufeta, the firm leverages both an experience investment team and a network of physician-scientists to focus on company creation and venture investing. The investment themes include cell therapy, gene therapy, artificial intelligence/machine learning applied to drug discovery, synthetic biology and regenerative medicine.

The investment platform includes a network of more than 1,200 top physician and scientist leaders across 33 major academic medical centers and research institutions in the U.S. The Medical Excellence Capital team operates out of the significant health care innovation markets New York, California, and Pennsylvania.

“Through warm relationships in the medical research community cultivated while CEO of MedEx, I became acutely aware of numerous underserved, yet exciting, opportunities to catalyze healthcare innovation,” said Prufeta in a statement. “As MEC launched, we were thrilled to add to the MEC investment team three seasoned investment professionals having decades of experience from their tenures at Domain Associates.”

The firm views the next decade as being one that will be consequential with respect to healthcare innovation with a greater impact on patients and their families, added Brian Halak, MEC managing partner.

“We are seeing exciting discoveries and technologies in multiple areas of healthcare,” added Eric Heil, MEC managing partner in a statement. “We believe that with this exclusive medical network, MEC is well positioned to accelerate the development of these discoveries in critical unmet need areas where patients and doctors can realize significant improvements in patient outcomes.”

The fund’s seven initial investments are in companies leading research in novel therapies for Parkinson’s disease, cancer and ALS. The investments were in: Aspen Neuroscience; Immunitas Therapeutics; Nobias Therapeutics; Pleno and ProJenX.

Kim Kamdar, Ph.D., MEC Managing Partner, added, “We focus our energies on developing successful partnerships with creative scientists whom we believe have the best ideas,” commented Kim Kamdar, MEC managing partner, in a statement. “Our operating structure is dedicated to fully support early-stage ventures at the Company Creation, Seed, Series A and Series B stages.”

ShareTweetShareSendSend
Previous Post

New Mexico SIC allocates $200m to infrastructure funds

Next Post

Argyle, Sembler partner for $1.5bn in Sunbelt real estate

Related Posts

NY pension adds $1.2bn across PE, credit, HF and real estate programs
Pensions

NY pension adds $1.2bn across PE, credit, HF and real estate programs

Texas fund allocates $90m to private markets, reviews annual plan
Pensions

Texas fund allocates $90m to private markets, reviews annual plan

Vision Ridge raises latest sustainable real assets fund
Real Estate/Infrastructure

Vision Ridge raises latest sustainable real assets fund

NJ DOI invests with existing alts managers
Pensions

NJ DOI invests with existing alts managers

Vidrio expands Qontigo partnership with portfolio and risk enhancements
Hedge Funds

Vidrio expands Qontigo partnership with portfolio and risk enhancements

Next Post
Argyle, Sembler partner for $1.5bn in Sunbelt real estate

Argyle, Sembler partner for $1.5bn in Sunbelt real estate

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Atalaya closes special opportunities fund at $1.8bn

Atalaya closes special opportunities fund at $1.8bn

NY pension adds $1.2bn across PE, credit, HF and real estate programs

NY pension adds $1.2bn across PE, credit, HF and real estate programs

Bridge collects $2.26bn for multifamily housing

Bridge collects $2.26bn for multifamily housing

AI hedge fund Castle Ridge builds success with multi-model system

AI hedge fund Castle Ridge builds success with multi-model system

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research
  • Subscribe
  • Log In

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In

© 2019-2022, All Rights Reserved  |  BMV Digital

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

Cookie Consent
We do not use cookies on our website other than those that are strictly necessary for the website to function. By clicking “Accept”, you consent to the use of all six strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo